Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |